ArticleThe Journal of antimicrobial chemotherapy2026
Global dissemination of optrA-mediated linezolid resistance in enterococci.
Article in The Journal of antimicrobial chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Genomic insights into an optrA-carrying plasmid associated with linezolid resistance in clinical Enterococcus faecalis isolates, Argentina.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
objectivesAcquired resistance to last-line linezolid has emerged in Enterococcus spp. and can be conferred by the optrA gene. Here, we study the global genomic context of optrA in E. faecalis and E. faecium, to understand its dissemination pattern.
methodsWe identified 565 enterococcal genomes from NCBI and 86 optrA-containing enterococcal plasmids from the plasmid database, PLSDB. We characterized the plasmid replication and antimicrobial resistance genes of optrA-containing plasmids and the plasmid pangenome. To identify prevalent optrA genetic contexts, we mapped the genomes against PLSDB plasmid and transposon Tn6674 (prevalent in E. faecalis) sequences using minimap2.
resultsA greater proportion of E. faecium (47.3%: n = 70/149) carried the optrA gene on plasmids than E. faecalis (28.9%: n = 120/416). In E. faecalis, the major optrA contexts were represented either by a Tn6674 transposon (28.0%) or a plasmid-associated MDR fexA-optrA-erm(A) genetic unit (32.9%), and were associated with distinct E. faecalis phylogroups. In E. faecium, the dominant optrA contexts were the optrA-erm(A)/(B) genetic unit (24.2%), the fexA-optrA-erm(A) unit (16.8%), and the Tn6261 transposon (14.1%). We observed that in some E. faecalis and E. faecium plasmids, the fexA-optrA-erm(A) unit was flanked by IS1216E elements on both sides, suggesting the mobilization of this MDR gene cassette by IS1216E-like elements into diverse plasmid backgrounds.
conclusionsThis is the first study to investigate the genomic context of optrA in a phylogeographically diverse enterococcal genome collection. We demonstrated that mobile genetic elements play a key role in the global expansion of optrA and highlighted the underlying public health concern imposed by plasmids in drug-resistant enterococcal dissemination.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.